Literature DB >> 22147792

Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.

Sarah Coseo Markt1, Ana C Rodriguez, Robert D Burk, Allan Hildesheim, Rolando Herrero, Sholom Wacholder, Martha Hutchinson, Mark Schiffman.   

Abstract

BACKGROUND: Few studies have addressed the timing of cervical cytologic abnormalities and human papillomavirus (HPV) positivity during the course of an infection. It remains largely unknown how infections detected by HPV and cytology wax and wane relative to each other. The aim of this analysis was to assess the longitudinal relationship of abnormal cytology and HPV positivity in a 7-year prospective study of 2500 women in Guanacaste, Costa Rica.
METHODS: At each semiannual or annual visit, cervical specimens were screened using liquid-based cytology and tested for >40 HPV types with use of MY09/MY11 L1 degenerate primer polymerase chain reaction-based methods. On the basis of previous work, we separated prevalent and newly detected infections in younger and older women.
RESULTS: Among newly detected HPV- and/or cytology-positive events, HPV and cytology appeared together ∼60% of the time; when discordant, HPV tended to appear before cytology in younger and older women. Combining newly and prevalently detected events, HPV and cytology disappeared at the same time >70% of the time. When discordant, HPV tended to disappear after cytology in younger and older women.
CONCLUSIONS: Detection of HPV DNA and associated cytological abnormalities tend to come and leave together; however, when discordant, detection of HPV DNA tends to precede and/or last longer than associated cytologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147792      PMCID: PMC3256945          DOI: 10.1093/infdis/jir746

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.

Authors:  M Schiffman; R Herrero; A Hildesheim; M E Sherman; M Bratti; S Wacholder; M Alfaro; M Hutchinson; J Morales; M D Greenberg; A T Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

2.  Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.

Authors:  R Herrero; M H Schiffman; C Bratti; A Hildesheim; I Balmaceda; M E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; J Morales; M Hutchinson; L Mango; M Alfaro; N W Potischman; S Wacholder; C Swanson; L A Brinton
Journal:  Rev Panam Salud Publica       Date:  1997-05

3.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

4.  The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop.

Authors: 
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

5.  Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study).

Authors:  S Syrjänen; I P Shabalova; N Petrovichev; V P Kozachenko; T Zakharova; A Pajanidi; J I Podistov; G Chemeris; L G Sozaeva; E V Lipova; I Tsidaeva; O G Ivanchenko; A A Pshepurko; S Zakharenko; R Nerovjna; L B Kljukina; O A Erokhina; M F Branovskaja; M Nikitina; V Grunberga; A Grunberg; A Juschenko; P Tosi; M Cintorino; R Santopietro; K J Syrjänen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-04-01       Impact factor: 2.435

6.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Comparisons of HPV DNA detection by MY09/11 PCR methods.

Authors:  Philip E Castle; Mark Schiffman; Patti E Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila Lorincz; John E Schussler; Robert D Burk
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

8.  High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.

Authors:  Patti E Gravitt; Melinda Butsch Kovacic; Rolando Herrero; Mark Schiffman; Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Ana-Cecilia Rodriguez; Robert D Burk
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

9.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

10.  High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women.

Authors:  Angela Watt; David Garwood; Maria Jackson; Novie Younger; Camille Ragin; Monica Smikle; Horace Fletcher; Norma McFarlane-Anderson
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

View more
  2 in total

1.  Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.

Authors:  Lauren E Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

2.  Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China.

Authors:  Dai Zhang; Ting Li; Lei Chen; Xiaosong Zhang; Gengli Zhao; Zhaohui Liu
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.